APUS Stock: Apimeds Pharmaceuticals US, Inc Stock Price, Analysis & Insights
Get live apus stock price $3.08, comprehensive Apimeds Pharmaceuticals US, Inc stock analysis, charts, news, and expert forecast. Real-time apus stock data and investment insights.
Loading chart...
Company Overview
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
Company Information
- CEO
- Erik C. Emerson
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2
Contact Information
- Website
- https://www.apimedsus.com
- Address
- 2 East Broad Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -3.22) may provide portfolio stability
Business Model & Strategy
Apimeds Pharmaceuticals US, Inc operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Erik C. Emerson, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Apimeds Pharmaceuticals US, Inc competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 38.7 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Apimeds Pharmaceuticals US, Inc provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Apimeds Pharmaceuticals US, Inc should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Apimeds Pharmaceuticals US, Inc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Apimeds Pharmaceuticals US, Inc
- ⚠Investors should consider how Apimeds Pharmaceuticals US, Inc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
38.70M
P/E Ratio
-9.62
Beta
-3.22
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 38.70M market capitalization
- Trading Volume: 262.12K shares traded today
- Price Range: 52-week range of $1.37 - $4.03
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc (APUS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 38.70M, the company represents a significant player in its market. The stock is currently trading at $3.08 with a negativedaily change of 20.92%.
The company's 2 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -9.62, beta of -3.22, and 52-week price range from $1.37 to $4.03when evaluating investment opportunities.
Why Invest in Apimeds Pharmaceuticals US, Inc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Erik C. Emerson
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.